These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 36682965)

  • 1. Positive rechallenge of hemophagocytic lymphohistiocytosis in a patient treated with isoniazide, pembrolizumab, carboplatine and pemetrexed.
    Bertin B; Auffret M; Chabert P
    Therapie; 2023; 78(6):762-764. PubMed ID: 36682965
    [No Abstract]   [Full Text] [Related]  

  • 2. Hemophagocytic lymphohistiocytosis secondary to pembrolizumab treatment with insufficient response to high-dose steroids.
    Lorenz G; Schul L; Bachmann Q; Angermann S; Slotta-Huspenina J; Heemann U; Küchle C; Schmaderer C; Jäger M; Tauber R; Retz M; Moog P
    Rheumatology (Oxford); 2019 Jun; 58(6):1106-1109. PubMed ID: 30668880
    [No Abstract]   [Full Text] [Related]  

  • 3. Pembrolizumab-induced Autoimmune Hemolytic Anemia and Hemophagocytic Lymphohistiocytosis in Non-small Cell Lung Cancer.
    Okawa S; Kayatani H; Fujiwara K; Ozeki T; Takada K; Iwamoto Y; Minami D; Sato K; Shibayama T
    Intern Med; 2019; 58(5):699-702. PubMed ID: 30828042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemophagocytic Lymphohistiocytosis in a Patient with Rheumatoid Arthritis on Pembrolizumab for Lung Adenocarcinoma.
    Akagi Y; Awano N; Inomata M; Kuse N; Tone M; Yoshimura H; Jo T; Takada K; Kumasaka T; Izumo T
    Intern Med; 2020 Apr; 59(8):1075-1080. PubMed ID: 32009093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two cases of lung cancer with hemophagocytic lymphohistiocytosis caused by immune checkpoint inhibitors.
    Kurozumi A; Takahashi H; Watanabe T; Iwasaki Y
    Thorac Cancer; 2021 May; 12(10):1625-1628. PubMed ID: 33783978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical characteristics, treatment, and management of pembrolizumab induced hemophagocytic lymphohistiocytosis.
    Wang C; Sun W; Li Z; Wu T; Fang W
    Invest New Drugs; 2023 Dec; 41(6):834-841. PubMed ID: 37897650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 24-Month Overall Survival from KEYNOTE-021 Cohort G: Pemetrexed and Carboplatin with or without Pembrolizumab as First-Line Therapy for Advanced Nonsquamous Non-Small Cell Lung Cancer.
    Borghaei H; Langer CJ; Gadgeel S; Papadimitrakopoulou VA; Patnaik A; Powell SF; Gentzler RD; Martins RG; Stevenson JP; Jalal SI; Panwalkar A; Yang JC; Gubens M; Sequist LV; Awad MM; Fiore J; Saraf S; Keller SM; Gandhi L
    J Thorac Oncol; 2019 Jan; 14(1):124-129. PubMed ID: 30138764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pembrolizumab associated hemophagocytic lymphohistiocytosis.
    Shah D; Shrestha R; Ramlal R; Hatton J; Saeed H
    Ann Oncol; 2017 Jun; 28(6):1403. PubMed ID: 28368439
    [No Abstract]   [Full Text] [Related]  

  • 9. Hemophagocytic syndrome associated with pembrolizumab therapy successfully controlled by cyclosporin.
    Sakai Y; Nakamura K; Midorikawa H; Osawa K; Shirai T; Sano T; Kiniwa Y; Nakazawa H; Okuyama R
    J Dermatol; 2020 Dec; 47(12):e422-e423. PubMed ID: 32860242
    [No Abstract]   [Full Text] [Related]  

  • 10. Cytokine-directed therapy with tocilizumab for immune checkpoint inhibitor-related hemophagocytic lymphohistiocytosis.
    Özdemir BC; Latifyan S; Perreau M; Fenwick C; Alberio L; Waeber G; Spertini F; de Leval L; Michielin O; Obeid M
    Ann Oncol; 2020 Dec; 31(12):1775-1778. PubMed ID: 32858151
    [No Abstract]   [Full Text] [Related]  

  • 11. Hemophagocytic lymphohistiocytosis associated with dabrafenib and trametinib combination therapy following pembrolizumab administration for advanced melanoma.
    Sasaki K; Uehara J; Iinuma S; Doi H; Honma M; Toki Y; Ishida-Yamamoto A
    Ann Oncol; 2018 Jul; 29(7):1602-1603. PubMed ID: 29741568
    [No Abstract]   [Full Text] [Related]  

  • 12. Haemophagocytic lymphohistiocytosis complicating pembrolizumab treatment for metastatic breast cancer in a patient with the
    Al-Samkari H; Snyder GD; Nikiforow S; Tolaney SM; Freedman RA; Losman JA
    J Med Genet; 2019 Jan; 56(1):39-42. PubMed ID: 30287596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment-related hemophagocytic lymphohistiocytosis due to atezolizumab: a case report and review of the literature.
    Rubio-Perez J; Rodríguez-Perez ÁR; Díaz-Blázquez M; Moreno-García V; Dómine-Gómez M
    J Med Case Rep; 2022 Oct; 16(1):365. PubMed ID: 36195892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pembrolizumab plus chemotherapy for first-line treatment of metastatic nonsquamous non-small-cell lung cancer: a network meta-analysis.
    Frederickson AM; Arndorfer S; Zhang I; Lorenzi M; Insinga R; Arunachalam A; Burke TA; Simon GR
    Immunotherapy; 2019 Apr; 11(5):407-428. PubMed ID: 30712477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alemtuzumab treatment for hemophagocytic lymphohistiocytosis.
    Machaczka M; Vaktnäs J; Chiang SC; Bryceson YT
    Nat Rev Clin Oncol; 2010 Oct; 7(10):. PubMed ID: 21080519
    [No Abstract]   [Full Text] [Related]  

  • 16. Carboplatin and pemetrexed with or without pembrolizumab for advanced, non-squamous non-small-cell lung cancer: a randomised, phase 2 cohort of the open-label KEYNOTE-021 study.
    Langer CJ; Gadgeel SM; Borghaei H; Papadimitrakopoulou VA; Patnaik A; Powell SF; Gentzler RD; Martins RG; Stevenson JP; Jalal SI; Panwalkar A; Yang JC; Gubens M; Sequist LV; Awad MM; Fiore J; Ge Y; Raftopoulos H; Gandhi L;
    Lancet Oncol; 2016 Nov; 17(11):1497-1508. PubMed ID: 27745820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tocilizumab as an Adjuvant Therapy for Hemophagocytic Lymphohistiocytosis Associated With Visceral Leishmaniasis.
    Rios-Fernández R; Callejas-Rubio JL; García-Rodríguez S; Sancho J; Zubiaur M; Ortego-Centeno N
    Am J Ther; 2016; 23(5):e1193-6. PubMed ID: 25768375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Randomized Phase III Study of Pembrolizumab Versus Pembrolizumab-Carboplatin-Pemetrexed for Locally Advanced or Metastatic Nonsquamous Non-small-cell Lung Cancer with PD-L1 50% or more (LAPLACE-50): Study Protocol.
    Kogure Y; Hashimoto H; Oki M
    Clin Lung Cancer; 2021 Nov; 22(6):e921-e924. PubMed ID: 34053861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An unforeseen reality: Hemophagocytic lymphohistiocytosis following alemtuzumab treatment for a multiple sclerosis.
    Ošep AB; Brecl E; Škerget M; Savšek L
    Clin Neurol Neurosurg; 2023 May; 228():107675. PubMed ID: 36965418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful treatment of a child with idiopathic multicentric Castleman disease associated with hemophagocytic lymphohistiocytosis using tocilizumab.
    Wei A; Ma H; Li Z; Zhang L; Zhang R; Wang T
    Pediatr Blood Cancer; 2019 Jul; 66(7):e27759. PubMed ID: 30989798
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.